Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Non-Current Assets (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Other Non-Current Assets for 4 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 81.76% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 81.76% year-over-year, with the annual reading at $2.5 million for FY2025, 81.76% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $2.5 million at LENZ Therapeutics, up from $1.6 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.5 million in Q4 2025, with the low at $1.7 in Q3 2022.
  • Average Other Non-Current Assets over 4 years is $1.4 million, with a median of $1.7 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets skyrocketed 99999900.0% in 2023, then plummeted 98.76% in 2024.
  • Over 4 years, Other Non-Current Assets stood at $1.7 million in 2022, then changed by 0.0% to $1.7 million in 2023, then fell by 17.76% to $1.4 million in 2024, then skyrocketed by 81.76% to $2.5 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2.5 million, $1.6 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.